DownRightNowNews
Banking & Finance

Banking & Finance News

Banking updates, fintech news, market movements, crypto, stock analysis, and payment system developments.

Showing 109–126 of 253 stories

Banking & Finance17h ago

American States Water (AWR), Why Is Its Latest Update Drawing Attention?

American States Water (AWR) is gaining attention after its August 5 earnings release, which reported higher quarterly and half-year revenue and net income, alongside an 8.2% increase in its quarterly dividend. The stock has seen significant share price appreciation year-to-date, suggesting building momentum. Despite positive performance, Simply Wall St's analysis indicates the stock is currently overvalued with a fair value estimate of $84 compared to its last closing price of $88.97, raising questions about upside for new buyers.

SSimply Wall Street
Banking & Finance17h ago

ASML Holding N.V. $ASML Shares Sold by Oppenheimer Asset Management Inc.

Oppenheimer Asset Management Inc. reduced its stake in ASML Holding N.V. by 6.3% in the second quarter, selling 2,373 shares and retaining 35,581 shares valued at approximately $70.8 million. Despite this sale, analyst sentiment remains largely positive, with a "Moderate Buy" consensus rating and an average price target of $1,970.33 for ASML, which recently reported strong quarterly revenues and earnings. The article also notes other institutional investors have recently adjusted their positions in the semiconductor company.

MMarketBeat
Banking & Finance17h ago

XPO (XPO) Could Be 9% Undervalued After Freight Demand Recovery Gains Pace

XPO (XPO) is attracting investor attention due to a recovery in freight demand, growing shipments, and tonnage, coupled with tighter transport capacity. Despite a significant year-to-date share price return, Simply Wall St's analysis suggests XPO could be 9% undervalued with a fair value of $231 per share, driven by AI-powered optimizations and anticipated margin expansion. However, concerns remain regarding XPO's high P/E ratio compared to the industry average and potential risks from cyclical freight demand and rising labor costs.

SSimply Wall Street
Banking & Finance17h ago

CarMax, Inc. $KMX Shares Sold by Qsemble Capital Management LP

Qsemble Capital Management LP significantly reduced its stake in CarMax, Inc. (KMX) by 81% in the second quarter, selling over 130,000 shares. Despite this, CarMax reported strong quarterly revenue of $8.01 billion and exceeded EPS estimates, though its EPS was down year-over-year. Analyst sentiment is mixed, with a recent upgrade to "Strong Buy" from Zacks but an overall "Hold" consensus, while company insiders have been purchasing shares.

MMarketBeat
Banking & Finance17h ago

Oppenheimer Asset Management Inc. Invests $9.09 Million in Pool Corporation $POOL

Oppenheimer Asset Management Inc. has acquired a new stake in Pool Corporation (NASDAQ:POOL) valued at approximately $9.09 million, purchasing 42,318 shares in the second quarter. Other institutional investors have also adjusted their holdings in Pool, which saw its stock trading down 2.9% recently. The company announced a quarterly dividend and its Board of Directors initiated a share buyback program of $600 million, suggesting the company believes its shares are undervalued.

MMarketBeat
Banking & Finance17h ago

Phillips 66 (PSX) Posts Strong Q2 And Pipeline Plans, Is The Upside Already Priced In?

Phillips 66 reported strong Q2 2026 results with increased sales, revenue, and earnings, alongside progress on its US$5 billion Western Gateway Pipeline project. The company has seen significant share price appreciation, with a 95.47% total shareholder return over the past year. While some analysts view PSX as overvalued based on current pricing against fair value estimates, Simply Wall St's DCF model suggests a much higher fair value, indicating potential for significant upside.

SSimply Wall Street
Banking & Finance17h ago

AVAH Jumps As Aveanna Healthcare Wins Wave Of Analyst Upgrades

Aveanna Healthcare Holdings Inc. (AVAH) saw its stock rise by 9.11% following strong Q2 2026 results that surpassed analyst estimates for revenue and adjusted EPS, leading to increased guidance for 2026. Major firms like Raymond James, BMO Capital, Deutsche Bank, and UBS raised their price targets, signaling renewed institutional confidence. Despite high leverage, the company's positive free cash flow and rising ROIC indicate strengthening fundamentals, with technical analysis suggesting an intermediate uptrend.

TTimothy Sykes
Banking & Finance17h ago

Regency Centers’ Higher Payouts and Raised Guidance Might Change The Case For Investing In REG

Regency Centers recently declared higher quarterly cash dividends and raised its full-year Nareit FFO and same-property NOI guidance, signaling confidence in its operating performance and a continued focus on distributing cash to shareholders. This move reinforces the REIT's income-focused thesis, emphasizing the durability of grocery-anchored retail and its ability to maintain leased properties and strong cash flow. While the increased guidance suggests resilience, investors should remain aware of potential risks such as shifts in tenant health and market dynamics.

SSimply Wall Street
Banking & Finance17h ago

Biohaven (BHVN) Could Be 73% Undervalued As Regeneron Deal Expands

Biohaven (BHVN) has expanded its oncology collaboration with Regeneron Pharmaceuticals, leading to recent stock momentum despite a longer history of weak returns and losses. Simply Wall St's Discounted Cash Flow (DCF) model estimates BHVN to be 73% undervalued with a fair value of $54.53 against its current trading price of $14.64, based on assumptions of future revenue and cash generation. However, the company faces significant clinical and regulatory hurdles, and its high Price-to-Book ratio of 180.9x compared to an industry average of 2.5x suggests high valuation risk.

SSimply Wall Street
Banking & Finance17h ago

Does Raised 2026 EBITDA Guidance And Expansion Strategy Change The Bull Case For Acadia Healthcare (ACHC)?

Acadia Healthcare has increased its 2026 adjusted EBITDA guidance and is pursuing network expansion despite facing operating and legal costs. While this indicates management's growing confidence in its expansion strategy, concerns persist regarding eroding earnings quality due to unresolved legal and regulatory investigations. The article suggests that while the guidance uplift is positive, the impact on durable profitability and the risks associated with legal costs remain central to the investment narrative.

SSimply Wall Street
Banking & Finance17h ago

H&R Block (NYSE: HRB) posts $3.95B revenue and 12% higher dividend

H&R Block (NYSE: HRB) reported solid fiscal year 2026 results with $3.95 billion in consolidated revenue, driven by increased U.S. assisted tax preparation revenues and growth in Wave®. The company also announced a 12.0% increase in dividends to $1.68 per share and repurchased 10.5 million shares, demonstrating significant capital returns to shareholders. Despite facing intense competition and regulatory changes, H&R Block continues to focus on human capital, digital innovation, and managing operational risks, including those related to artificial intelligence and cybersecurity.

SStock Titan
Banking & Finance17h ago

ENS Q1 Earnings and Sales Beat on Pricing, Margin Expansion

EnerSys (ENS) reported strong first-quarter fiscal 2027 results, surpassing Zacks Consensus Estimates for both earnings and sales. The company's adjusted earnings per share increased by 64.1% year over year, driven by margin expansion, IRC 45X benefits, and a tariff refund. Net sales grew 4.8%, benefiting from pricing, foreign currency translation, and organic volume, with significant strength seen in Network & Infrastructure Solutions and Precision Power Solutions, despite softness in Industrial Mobility Solutions.

TTradingView
Banking & Finance17h ago

A10 Networks general counsel sells $392,435 in stock By Investing.com

A10 Networks' General Counsel, Robert Scott Weber, sold 14,086 shares of company stock worth approximately $392,435 on August 11, 2026. This transaction was part of a Rule 10b5-1 trading plan. Despite the sale, Weber still directly holds 50,586 shares, and the company has shown strong financial performance with a 61% return over the past year and raised its full-year outlook.

IInvesting.com Canada
Banking & Finance15 Aug

Avalo Therapeutics CMO Mittie Doyle sells $13,580 in stock

Mittie Doyle, CMO at Avalo Therapeutics (NASDAQ:AVTX), sold 679 shares for $13,580 after exercising stock options under a Rule 10b5-1 trading plan. Following these transactions, she directly holds 51,776 shares and 114,413 stock options. This news follows Avalo's inclusion in the Russell 2000 and 3000 indexes, the appointment of Ron Philip to its board, and positive analyst ratings.

IInvesting.com
Banking & Finance15 Aug

Why You Should Consider Buying ResMed Stock After Its First

ResMed (RMD) has issued its first annual guidance, targeting $5.75B-$5.85B in FY27 revenue and $12.00-$12.25 non-GAAP EPS, implying a 12-14% core EPS growth when temporary headwinds are excluded. While street analysts are cautious and have trimmed price targets, TIKR's model values ResMed stock at $346 by mid-2031, suggesting a 54% total return. This indicates a disconnect between analyst sentiment and the company's underlying growth story, particularly as temporary drags resolve.

TTIKR.com
Banking & Finance15 Aug

Ambev Shares Fall 6.7% as Brazilian Real Weakens, Intensifying Selloff

Ambev's shares fell by 6.7% as the Brazilian real weakened, contributing significantly to a broader stock selloff despite strong Q2 operating results. The depreciation of the real accounted for nearly two percentage points of the decline in Ambev's ADRs. The company reported solid organic EBITDA growth and normalized profit increases in Q2, but analysts maintain a cautious stance due to currency risks and soft category demand.

TTechStock²

Headlines and briefs on this site are for information only. Always verify details on the original source or live status page.

Read Disclaimer